Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0000899243-23-003734

President and CEO acquired 205,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BEN-MAIMON CAROLE · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-31 Grant or award : show line 1 in the form +205,000 261,829 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-31 Grant or award : show line 2 in the form Stock Option (Right to Buy) +325,000 325,000 D
Loading xslF345X03/doc4.xml…